Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Market Cap	3.66B
Revenue (ttm)	6.06B
Net Income (ttm)	355.43M
Shares Out	4.11B
EPS (ttm)	0.09
PE Ratio	10.30
Forward PE	n/a
Dividend	0.06 (7.06%)
Ex-Dividend Date	Nov 14, 2024

Volume	2,000
Average Volume	19,150
Open	0.8900
Previous Close	0.8500
Day's Range	0.8900 - 0.8900
52-Week Range	0.7000 - 1.0100
Beta	0.87
RSI	52.24
Earnings Date	Apr 16, 2025

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 1,604
• Stock Exchange: Philippine Stock Exchange
• Ticker Symbol: EURO

Financial Performance

In 2023, PSE:EURO's revenue was 5.26 billion, an increase of 24.62% compared to the previous year's 4.22 billion. Earnings were 289.95 million, an increase of 45.06%.